Cite
Jackson MR, Stevenson K, Chahal SK, et al. Low-Dose Lung Radiation Therapy for COVID-19 Lung Disease: A Preclinical Efficacy Study in a Bleomycin Model of Pneumonitis. Int J Radiat Oncol Biol Phys. 2021;112(1):197-211doi: 10.1016/j.ijrobp.2021.08.029.
Jackson, M. R., Stevenson, K., Chahal, S. K., Curley, E., Finney, G. E., Gutierrez-Quintana, R., Onwubiko, E., Rupp, A., Strathdee, K., Williams, K., MacLeod, M. K. L., McSharry, C., & Chalmers, A. J. (2022). Low-Dose Lung Radiation Therapy for COVID-19 Lung Disease: A Preclinical Efficacy Study in a Bleomycin Model of Pneumonitis. International journal of radiation oncology, biology, physics, 112(1), 197-211. https://doi.org/10.1016/j.ijrobp.2021.08.029
Jackson, Mark R, et al. "Low-Dose Lung Radiation Therapy for COVID-19 Lung Disease: A Preclinical Efficacy Study in a Bleomycin Model of Pneumonitis." International journal of radiation oncology, biology, physics vol. 112,1 (2022): 197-211. doi: https://doi.org/10.1016/j.ijrobp.2021.08.029
Jackson MR, Stevenson K, Chahal SK, Curley E, Finney GE, Gutierrez-Quintana R, Onwubiko E, Rupp A, Strathdee K, Williams K, MacLeod MKL, McSharry C, Chalmers AJ. Low-Dose Lung Radiation Therapy for COVID-19 Lung Disease: A Preclinical Efficacy Study in a Bleomycin Model of Pneumonitis. Int J Radiat Oncol Biol Phys. 2022 Jan 01;112(1):197-211. doi: 10.1016/j.ijrobp.2021.08.029. Epub 2021 Aug 31. PMID: 34478832; PMCID: PMC8406661.
Copy
Download .nbib